inside_banner

Products

Uracil Pyrimidine-2,4(1H,3H)-dione

Description:


  • Nomen chemicum:Uracil Pyrimidine-2,4(1H,3H)-dione
  • CAS No.:66-22-8
  • Deprecatus est CAS;144104-68-7,42910-77-0,4433-21-0,4433-24-3,766-19-8,138285-60-6,153445-42-2,51953-19-6,138285-60- 6,153445-42-2,42910-77-0,4433-24-3,51953-19-6,766-19-8
  • Formulae hypotheticae:C4H4N2O2
  • Atomis computatis:4 atomi carbonis, 4 atomi Hydrogenii,2 atomi NITROGENII, 2 atomi Oxygeni;
  • Pondus hypotheticum:114.089
  • Hs Codicis.2933.59
  • Communitas Europaea (EC) Number:200-621-9
  • NSC Number:759649,29742,3970
  • Unii:56HH86ZVCT
  • DSSTox substantia ID:DTXSID4021424
  • Nikkaji Number:J4.842I
  • Vicipaedia:Uracil
  • Vicimedia:Q182990
  • NCI Thesaurus Codicis:C917
  • Metabolomics opificinae ID:37192
  • ChEMBL ID:CHEMBL566
  • Mol lima: 66-22-8.mol
  • Product Detail

    Product Tags

    product-img (1)

    Synonyma: Uracil

    Chemical Property of Uracil

    Aspectus / Color: cerussa
    ● Vapor Pressure: 2.27E-08mmHg ad 25°C
    liquefactio Point:>300 °C (lit.)
    Refractivus Index: 1.501
    Fervens Point:440.5°C at 760 mmHg
    PKA: 9.45(at 25℃)
    Flash Point:220.2oC
    PSA:65.72000
    Density: 1.322 g/cm3
    ● LogP: -0.93680

    Repono Temp.:+15C ad +30C
    ● Solubility.: Aqueum Acidum (paululum), DMSO (Pauliter, Calefactum, Sonicatum), Methanolum (Pauliter;
    Aqua Solubility.:SOLUBILIS in aqua calida
    ● XLogP3: -1.1
    Hydrogenium Bond Donor Comes: 2
    Hydrogenium Bond Acceptoris Comitis:2
    Rotatable vinculo comitis: 0
    ● Exacta Missa: 112.027277375
    Gravis Atom comitis: 8
    Complexity:161

    Puritas / Quality

    99%, * data a rudis instructus

    Uracil * notitia ex tenui amet

    Safty Information

    Pictogram(s);product (2)Xi
    DISCRIMEN Codes:Xi
    Salus Denunciationes: 22-24/25

    Utilis

    ● Chemical Classes: Biological Agentia -> Acides Nucleicae et Derivativae
    ● CANONICI SMILES: C1=CNC(=O)NC1=O
    ● recentes ClinicalTrials: Studium 0.1% UraciL Topical Cream (UTC) ad praeventionis manus-pedis syndrome
    Recent EU Clinical Trials: Onderzoek naar de farmacokinetiek van uracil na orale toediening bij pati?nten met colorectaal carcinoom.
    Recent NIPH Fuscae Tribulationes: Phase II probatio unguenti uracili pro ne capecitabine inducta syndrome manus pedis (HFS): .
    Usus: Ad investigationes diam, medicamenta synthesis;intermedia pharmaceutica adhibita, etiam in synthesi nitrogenea basis RNA nucleosidis organici adhibita.antineoplastic In diam investigationem.Uracil (Lamivudine EP Impurity F) est basis nitrogena in RNA nucleosides.
    ● Descriptio: Uracil basis pyrimidine est ac elementum fundamentale RNA ubi per vincula hydrogenii adenina ligat.Vertitur in uridinem nucleosidem per medietatem ribosi addito, deinde ad nucleotidem uridine monophosphate, addita globi phosphatis.


  • Previous:
  • Deinde:

  • Epistulam tuam hic scribe et mitte nobis